位置:首页 > 蛋白库 > DCNL2_HUMAN
DCNL2_HUMAN
ID   DCNL2_HUMAN             Reviewed;         259 AA.
AC   Q6PH85; Q5JSA5; Q5JSA6; Q5JSA7; Q9NVJ1; Q9NXR6;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 143.
DE   RecName: Full=DCN1-like protein 2 {ECO:0000305};
DE            Short=DCNL2 {ECO:0000303|PubMed:23201271};
DE   AltName: Full=DCUN1 domain-containing protein 2;
DE   AltName: Full=Defective in cullin neddylation protein 1-like protein 2;
GN   Name=DCUN1D2 {ECO:0000312|HGNC:HGNC:20328}; Synonyms=C13orf17, DCUN1L2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH CUL1; CUL2; CUL3; CUL4A; CUL4B; CUL5 AND UBE2M, AND
RP   FUNCTION.
RX   PubMed=19617556; DOI=10.1073/pnas.0812528106;
RA   Meyer-Schaller N., Chou Y.C., Sumara I., Martin D.D., Kurz T., Katheder N.,
RA   Hofmann K., Berthiaume L.G., Sicheri F., Peter M.;
RT   "The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at
RT   membranes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12365-12370(2009).
RN   [5]
RP   INTERACTION WITH CUL1; CUL2; CUL3; CUL4A; CUL4B; CUL5; CAND1; RBX1; RNF7;
RP   ELOB AND DDB1, SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF ASP-211;
RP   ALA-235 AND ASP-241, AND TISSUE SPECIFICITY.
RX   PubMed=26906416; DOI=10.1242/jcs.181784;
RA   Keuss M.J., Thomas Y., Mcarthur R., Wood N.T., Knebel A., Kurz T.;
RT   "Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.";
RL   J. Cell Sci. 129:1441-1454(2016).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.28 ANGSTROMS) OF 62-259 IN COMPLEX WITH UBC12
RP   PEPTIDE, FUNCTION, DOMAIN, AND INTERACTION WITH CUL1; CUL2; CUL3; CUL4A;
RP   CUL4B; CUL5; UBE2M AND UBE2F.
RX   PubMed=23201271; DOI=10.1016/j.str.2012.10.013;
RA   Monda J.K., Scott D.C., Miller D.J., Lydeard J., King D., Harper J.W.,
RA   Bennett E.J., Schulman B.A.;
RT   "Structural conservation of distinctive N-terminal acetylation-dependent
RT   interactions across a family of mammalian NEDD8 ligation enzymes.";
RL   Structure 21:42-53(2013).
CC   -!- FUNCTION: Contributes to the neddylation of all cullins by transferring
CC       NEDD8 from N-terminally acetylated NEDD8-conjugating E2s enzyme to
CC       different cullin C-terminal domain-RBX complexes and plays an essential
CC       role in the regulation of SCF (SKP1-CUL1-F-box protein)-type complexes
CC       activity. {ECO:0000269|PubMed:19617556, ECO:0000269|PubMed:23201271,
CC       ECO:0000269|PubMed:26906416}.
CC   -!- SUBUNIT: Interacts (via the DCUN1 domain) with the unneddylated
CC       cullins: interacts with CUL1, CUL2, CUL3, CUL4A, CUL4B and CUL5; these
CC       interactions promote the cullin neddylation and the identity of the
CC       cullin dictates the affinity of the interaction (PubMed:26906416,
CC       PubMed:23201271, PubMed:19617556). May also interact with regulators or
CC       subunits of cullin-RING ligases such as RBX1, RNF7, ELOB and DDB1;
CC       these interactions are bridged by cullins (PubMed:26906416). Interacts
CC       with CAND1; this interaction is bridged by cullins such as CUL3 and
CC       strongly inhibits the neddylation of CUL3. These CAND-cullin-DCNL
CC       complexes can only be neddylated in the presence of a substrate adapter
CC       (PubMed:26906416). Interacts (via DCUN1 domain) with the N-terminally
CC       acetylated form of UBE2M and UBE2F (PubMed:23201271, PubMed:19617556).
CC       {ECO:0000269|PubMed:19617556, ECO:0000269|PubMed:23201271,
CC       ECO:0000269|PubMed:26906416}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:26906416}. Nucleus
CC       {ECO:0000269|PubMed:26906416}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6PH85-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PH85-2; Sequence=VSP_015315, VSP_015316;
CC   -!- TISSUE SPECIFICITY: Mostly expressed in liver, kidney and brain.
CC       {ECO:0000269|PubMed:26906416}.
CC   -!- DOMAIN: The DCUN1 domain, also known as PONY domain, mediates the
CC       interaction with different cullins (PubMed:23201271). The DCUN1 domain
CC       mediates the interaction with the N-terminally acetylated NEDD8-
CC       conjugating E2s enzyme leading to the NEDD8 transfer from N-terminally
CC       acetylated NEDD8-conjugating E2s enzyme to different cullin C-terminal
CC       domain-RBX complexes; the neddylation efficiency correlates with the
CC       DCUN1D5-cullin and DCUN1D5-E2 interaction affinities (PubMed:23201271).
CC       {ECO:0000269|PubMed:23201271}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA90944.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK000099; BAA90944.1; ALT_INIT; mRNA.
DR   EMBL; AK001566; BAA91760.1; -; mRNA.
DR   EMBL; AL160251; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL442125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC056669; AAH56669.1; -; mRNA.
DR   CCDS; CCDS32013.1; -. [Q6PH85-1]
DR   RefSeq; NP_001014305.1; NM_001014283.1. [Q6PH85-1]
DR   PDB; 4GAO; X-ray; 3.28 A; A/B/D/G=62-259.
DR   PDBsum; 4GAO; -.
DR   AlphaFoldDB; Q6PH85; -.
DR   SMR; Q6PH85; -.
DR   BioGRID; 120504; 33.
DR   DIP; DIP-60768N; -.
DR   ELM; Q6PH85; -.
DR   IntAct; Q6PH85; 12.
DR   STRING; 9606.ENSP00000417706; -.
DR   BindingDB; Q6PH85; -.
DR   ChEMBL; CHEMBL4295866; -.
DR   iPTMnet; Q6PH85; -.
DR   PhosphoSitePlus; Q6PH85; -.
DR   BioMuta; DCUN1D2; -.
DR   DMDM; 73919224; -.
DR   EPD; Q6PH85; -.
DR   jPOST; Q6PH85; -.
DR   MassIVE; Q6PH85; -.
DR   MaxQB; Q6PH85; -.
DR   PaxDb; Q6PH85; -.
DR   PeptideAtlas; Q6PH85; -.
DR   PRIDE; Q6PH85; -.
DR   ProteomicsDB; 67123; -. [Q6PH85-1]
DR   ProteomicsDB; 67124; -. [Q6PH85-2]
DR   Antibodypedia; 48901; 98 antibodies from 15 providers.
DR   DNASU; 55208; -.
DR   Ensembl; ENST00000375403.6; ENSP00000364552.2; ENSG00000150401.15. [Q6PH85-2]
DR   Ensembl; ENST00000478244.6; ENSP00000417706.1; ENSG00000150401.15. [Q6PH85-1]
DR   GeneID; 55208; -.
DR   KEGG; hsa:55208; -.
DR   MANE-Select; ENST00000478244.6; ENSP00000417706.1; NM_001014283.2; NP_001014305.1.
DR   UCSC; uc001vtr.2; human. [Q6PH85-1]
DR   CTD; 55208; -.
DR   DisGeNET; 55208; -.
DR   GeneCards; DCUN1D2; -.
DR   HGNC; HGNC:20328; DCUN1D2.
DR   HPA; ENSG00000150401; Tissue enhanced (heart muscle, skeletal muscle, tongue).
DR   neXtProt; NX_Q6PH85; -.
DR   OpenTargets; ENSG00000150401; -.
DR   PharmGKB; PA134941036; -.
DR   VEuPathDB; HostDB:ENSG00000150401; -.
DR   eggNOG; KOG3077; Eukaryota.
DR   GeneTree; ENSGT00940000157453; -.
DR   HOGENOM; CLU_047042_0_2_1; -.
DR   InParanoid; Q6PH85; -.
DR   OMA; NEDQAWP; -.
DR   OrthoDB; 1418097at2759; -.
DR   PhylomeDB; Q6PH85; -.
DR   TreeFam; TF313332; -.
DR   PathwayCommons; Q6PH85; -.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   SignaLink; Q6PH85; -.
DR   BioGRID-ORCS; 55208; 8 hits in 1076 CRISPR screens.
DR   ChiTaRS; DCUN1D2; human.
DR   GenomeRNAi; 55208; -.
DR   Pharos; Q6PH85; Tchem.
DR   PRO; PR:Q6PH85; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q6PH85; protein.
DR   Bgee; ENSG00000150401; Expressed in apex of heart and 186 other tissues.
DR   ExpressionAtlas; Q6PH85; baseline and differential.
DR   Genevisible; Q6PH85; HS.
DR   GO; GO:0005737; C:cytoplasm; IMP:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IMP:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0097602; F:cullin family protein binding; IMP:UniProtKB.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0032182; F:ubiquitin-like protein binding; IBA:GO_Central.
DR   GO; GO:2000436; P:positive regulation of protein neddylation; IMP:UniProtKB.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; IBA:GO_Central.
DR   GO; GO:0045116; P:protein neddylation; IBA:GO_Central.
DR   GO; GO:2000434; P:regulation of protein neddylation; IMP:UniProtKB.
DR   Gene3D; 1.10.238.200; -; 1.
DR   InterPro; IPR014764; DCN-prot.
DR   InterPro; IPR042460; DCN1-like_PONY.
DR   InterPro; IPR005176; PONY_dom.
DR   InterPro; IPR009060; UBA-like_sf.
DR   PANTHER; PTHR12281; PTHR12281; 1.
DR   Pfam; PF03556; Cullin_binding; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   PROSITE; PS51229; DCUN1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation pathway.
FT   CHAIN           1..259
FT                   /note="DCN1-like protein 2"
FT                   /id="PRO_0000129501"
FT   DOMAIN          8..45
FT                   /note="UBA-like"
FT   DOMAIN          60..248
FT                   /note="DCUN1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00574"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BZJ7"
FT   VAR_SEQ         174..186
FT                   /note="DLEMAVAYWKLVL -> GSPPFLNVKALHH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_015315"
FT   VAR_SEQ         187..259
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_015316"
FT   MUTAGEN         211
FT                   /note="D->A: Loss of interaction with CUL1, CUL2, CUL3,
FT                   CULA4, CULA5 CAND1 and RBX1; when associated with R-235 and
FT                   A-241. Does not affect both nucleus and cytoplasm
FT                   localization; when associated with R-235 and A-241."
FT                   /evidence="ECO:0000269|PubMed:26906416"
FT   MUTAGEN         235
FT                   /note="A->R: Loss of interaction with CUL1, CUL2, CUL3,
FT                   CULA4, CULA5 CAND1 and RBX1; when associated with A-211 and
FT                   A-241. Does not affect both nucleus and cytoplasm
FT                   localization; when associated with A-211 and A-241."
FT                   /evidence="ECO:0000269|PubMed:26906416"
FT   MUTAGEN         241
FT                   /note="D->A: Loss of interaction with CUL1, CUL2, CUL3,
FT                   CULA4, CULA5 CAND1 and RBX1; when associated with A-211 and
FT                   R-235. Does not affect both nucleus and cytoplasm
FT                   localization; when associated with A-211 and R-235."
FT                   /evidence="ECO:0000269|PubMed:26906416"
FT   HELIX           62..70
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   STRAND          77..81
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           83..92
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           100..109
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           119..128
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           134..146
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           151..165
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   STRAND          171..174
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           175..185
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   TURN            187..189
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           193..202
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           210..222
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           238..247
FT                   /evidence="ECO:0007829|PDB:4GAO"
FT   HELIX           249..251
FT                   /evidence="ECO:0007829|PDB:4GAO"
SQ   SEQUENCE   259 AA;  30179 MW;  B12A33F80D419A28 CRC64;
     MHKLKSSQKD KVRQFMACTQ AGERTAIYCL TQNEWRLDEA TDSFFQNPDS LHRESMRNAV
     DKKKLERLYG RYKDPQDENK IGVDGIQQFC DDLSLDPASI SVLVIAWKFR AATQCEFSRK
     EFLDGMTELG CDSMEKLKAL LPRLEQELKD TAKFKDFYQF TFTFAKNPGQ KGLDLEMAVA
     YWKLVLSGRF KFLDLWNTFL MEHHKRSIPR DTWNLLLDFG NMIADDMSNY DEEGAWPVLI
     DDFVEYARPV VTGGKRSLF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024